NewsBenzingaHC Wainwright & Co. Reiterates Buy on Tango Therapeutics, Maintains $68 Price Target HC Wainwright & Co. Reiterates Buy on Tango Therapeutics, Maintains $68 Price Target Benzinga 2026.10.29 10:22 (GMT+0) Open on Benzinga Other news Hershey Q3 2026 Earnings Call Transcript Proto Labs Q3 2026 Earnings Call Transcript DoorDash Q3 2026 Earnings Call Transcript Oppenheimer Maintains Outperform on Ensign Group, Raises Price Target to $215 Keybanc Maintains Overweight on Alphabet, Lowers Price Target to $385 ATI Q3 2026 Earnings Call Transcript
